Highly recommended Clinical case reports webinar featuring Yolande Pijnenburg & Baayla DC Boon 👇

Great initiative, check out the list 👇

Fun fact: About a quarter of my emails since moving to Australia start with 'G’day Rik!'

🚨 NEW paper led by Gemma Salvadó in Nature Aging proposes a new CSF-only staging model to characterize #Alzheimer 's disease progression.

PDF: nature.com/articles/s4358…

w/Jake Vogel Alexa Pichet Binette Brian Gordon Suzanne E Schindler Oskar Hansson BioFINDER & Washington University Department of Neurology

🚨 NEW: Ismael Calandri shows that Argentina has a higher population-attributable fraction (PAF) for dementia + different risk factor weights vs worldwide estimates.

PDF: karger.com/ned/article/do…

w/Gill Livingston Regina Paradela @luCrivelliOk Ricardo F. Allegri Claudia Suemoto MD PhD MSc

It was great to present our work today at AD/PD - Advances in Science & Therapy on sex differences in (changes in) tau vs cognitive decline along the clinical AD continuum in the BioFINDER - associations w longitudinal cognition may depend on disease stage and levels of (changes in) tau PET 🧠👇👫

Asceneuron SA expands its Scientific Advisory Board, with the appointments of Dr Samantha Budd Haeberlein, Henrik Zetterberg, RikOssenkoppele , and Chris van Dyck, MD to support Phase II development of its lead asset ASN51 in #Alzheimers Disease.

👉asceneuron.com/news/asceneuro…

What’s not to like? Looking very much forward spending the next five months in #Melbourne .

A new milestone in AD biomarker development published Nature Medicine: Plasma p-tau217 is at least non-inferior to FDA-approved CSF markers. Great collab between BioFINDER & Washington University Department of Neurology, with a special shout-out to Gemma Salvadó who is truly making an impact.

I’m thrilled to announce that Nilton Custodio and I have been awarded an Alzheimer's Association grant for our ongoing research on Resilience to AD in Andean Indigenous. With this funding, we aim to explore the impact of RF and SDOH. #ENDALZ #ALZFunded Thanks to the entire crew!(tagged)

Found my mugshot alongside 11 Alzheimercentrum Amsterdam colleagues in this morning’s edition of the Dutch newspaper Het Parool!

What a terrific Year in Review of studies on atypical variants of #Alzheimer 's disease by Deepti Putcha!

Organized by our Atypical Alzheimer's Disease PIA, with the great panelists Baayla DC Boon, Rosaleena Mohanty, Keir Yong & Colin Groot.

Very proud of Denise Visser who brilliantly defended her PhD thesis “Optimizing the use of dynamic tau PET in Alzheimer’s disease”!

Great to see our large multi-cohort, UCSF MAC-led, study published The Lancet Neurology (open-access)! It shows that the clinical phenotype 'posterior cortical atrophy [PCA]' is highly specific for #Alzheimer 's disease pathology.

sciencedirect.com/science/articl…

On my way to the Human Amyloid Imaging conference in Miami, looking forward to great science and catching up with colleagues and friends! #HAI24

HumanAmyloidImaging

What is the most likely diagnosis in this 75 y/o M w/ history of Alzheimer’s disease on lecanemab (last infusion ~1 week prior) presenting w/ headache and confusion? 🧠

More images in 🧵

#MedEd #Neurology #medicine #radres #Neurosurgery #futureradres Andreas Charidimou MD, PhD

Some personal news: We will spend 5 months living and working in #Melbourne , starting by the end of February.

Let me know if you’d like to meet and discuss science (or other things)!

Do cognitive deficits persist after COVID-19 and, if so, what is their biological basis?

Our NEW pre-print under review in Nature Portfolio dx.doi.org/10.21203/rs.3.…

We report one-year cognitive, serum biomarker, and neuroimaging findings in 351 patients

A thread 1/n

Check out our new review on the amygdala in AD, led by the fantastic Kaitlin Stouffer! It was about time that this structure receives more attention in AD - we even argue for its involvement in an additional NFT progression pathway

tinyurl.com/amygdalaAD

Thread below👇🧵 (1/8)

A new ultra-sensitive immunoassay for the #tau pathology marker, p-tau205, in #CSF

link.springer.com/article/10.100…